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autosomal recessive form of RTA, but had strong vertical family history of deafness; the third child had normal hearing.
No abnormalities in total CA activity, isoenzyme distribution, or in electrophoretic mobility could be demonstrated in our three patients with RTA. This may be due to differences in methodology, genetic heterogeneity, or the appearance of the two findings may have been fortuitous. Although we used a different method for demonstrating CA B activity, no abnormality of CA B could be shown.
The finding of almost complete absence of CA B in the red blood cells of patients with thyrotoxicosis (15) and the demonstration that CA in rat renal cortex can be inhibited by parathyroid hormone (1) is further evidence that many different factors can influence C A activity. Therefore, a reduction in CA B activity in the red blood cells of a patient with RTA may not be the cause of the RTA but may be related to other factors, for example, secondary hyperparathyroidism which occurs in some patients with RTA (9).
CONCLUSION
Red blood cell carbonic anhydrase activity and the two isoenzymes, B and C, of carbonic anhydrase were normal in three children with distal renal tubular acidosis; two of these patients were deaf. Therefore, although defective red blood cell carbonic anhydrase B activity has been demonstrated previously in a child with renal tubular acidosis and deafness, this finding cannot be demonstrated in every patient with these two associated abnormalities.
all of these changes are spontaneously reversed and to investigate whether the chemical changes are correlated with brain functional deficits.
Cortisone and its natural and synthetic derivatives are used largely in human therapeutics. Furthermore, corticoids are used as fetal enzymatic pulmonary inductors when a premature delivery is expected. Fetal development can be affected by adverse conditions imposed on the maternal organism. These events frequently result in permanent or transitory disorders of maturational patterns. These disorders are intimately related to the developmental stage during which the subject receives the insult (1, 17) . Effects of different glucocorticoids on development have been reported by different authors. Sames and Leatham (14) showed that body weight is decreased when the chick embryo is treated with cortisone. Weight inhibition and defects in facial bones, tibia, and exteriorized viscera occur when cortisone is administered during early development of the chick embryo; when the drug is administered a t a later stage facial bones are not affected but body weight and osseous development present major disturbances (1 1). Malformations of limbs and palate are present in mice whose mothers were treated with hidrocortisone acetate in the course of pregnancy (7) . Some authors (1 5 , 19) reported that human fetal damage was minimal when mothers were treated with corticoids in the course of pregnancy, but they studied children at only birth. Other authors (12, 16) reported evidences of serious human damage.
In light of the known metabolic effects of glucocorticoids and the above mentioned developmental changes, the possibility that administration of 16-/3-metilprednisone might produce biochemical and structural changes in the nervous system of developing animals warrants consideration.
In the present work, 16-/3-metilprednisone was administered to pregnant rats. Some aspects of the chemical development of the brain were studied in the newborn up to the pubertal age.
MATERIALS AND METHODS
Inbred pregnant hooded rats were used. They were housed in a room maintained at 24" ? lo. They had free access to rat chow pellets and tap water throughout the experiments.
The litters studied had always six to eight animals. Larger o r smaller litters were discarded. One group of animals was treated daily during 5 days of pregnancy (from day 15 to day 19) by subcutaneous injection of a suspension of 16-/3-metilprednisone at a dose of 1.25 mg/kg/day. The rest of the animals were used as controls. Daily vaginal samples were obtained prior to and during pregnancy. The smears were processed by the Shorr method and examined qualitatively to determine the estrous cycle. The first day of pregnancy was defined as the first day in estrus with spermatozoids present and later followed by a prolonged diestrus and detectable fetuses. Body weight was controlled daily. The litters were killed within the first 24 hr of life (newborns), at 17 days, or at 45 days of age. The brain (cerebral hemispheres, including olfactory lobe) was rapidly dissected out from the meninges and larger blood vessels and weighed. The left halves of the brains were dried at 70' to a constant weight. Water content was calculated from the difference between wet and dry weights. Proteins and lipids were determined in the right half of the brain.
Total proteins were assayed by the method of Lowry (9). Lipids were extracted from brain samples with chloroform/methan01 2: 1, according to the method of Folch et al. (6) . The extract was dissolved with ethanol and aliquots were taken to determine total lipids (including unsaturate, free, and esterified fatty acids) by a colorimetric determination based on a modification of Chabrot and Charonnats using the sulfophosphovanillic reaction (20) , cholesterol (10) . and phospholipids (by a colorimetric determination of inorganic phosphate, after previous mineralization) (2) 
RESULTS

BODY WEIGHT
The rats from mothers treated with 16-/3-metilprednisone showed a statistically significant decrement in body weight at 17 days (Table 1) . No differences were found between treated and control animals, at birth nor at 45 days of life.
Body weight from birth to 45 days of life follows a logistic function, mathematically expressed by the equation: The values of treated animals were statistically lower than those of controls at 17 days of life.
DRY BRAIN WEIGHT
At 17 and 45 days of age treated animals showed a significantly decreased dry weight.
WATER CONTENT PER MG DRY BRAIN WEIGHT
At 45 days a significant increment of brain water'was evident as compared with untreated animals (Table 1 ). No differences in this parameter were found in the newborn or in the 17-day-old animals with respect to their controls.
BRAIN PROTEINS
Newborn and 17-day-old rats treated with 16-P-metilprednisone showed a remarkable decrease in brain proteins, as determined from wet tissue. This difference disappears at 45 days of life (Table 2 ).
BRAIN LIPIDS
A significant decrement of brain "total" lipids, cholesterol, and phospholipids became evident at 45 days in the treated animals ( Table 2) . Seventeen-day-old animals treated with the steroid had a decreased content of phospholipids but no differences were found in total lipids or in cholesterol ( Table 2 ) when compared with their respective control groups. No differences between sexes were found in any of the parameters that were studied.
DISCUSSION
In the present work, 16-0-metilprednisone was administered to pregnant rats in the last week of pregnancy. The cerebral development was studied in newborn, in 17-day-old, and in 45-day-old litters. These times of death were selected because they represent critical periods in the biochemical development of the brain; it is known that in the newborn and up to 10 days of age there is deposition of proteins and small deposition of lipids in the brain, and from this time up to 40 days of life there is great deposition of lipids and hence active myelination. This lipid increment occurs concomitantly with a decrease in the amount of water (18) .
Changes in body and cerebral weights and the decreased protein content of the latter would be in part due to the known catabolic effect of glucocorticoids on protein metabolism. This would be supported by the fact that during the last week of pregnancy there is an important cellular division in the rat tetal brain, and by the known inhibitory effect of glucocorticoids on brain cells which might be associated with a decreased cellular number (3) .
At about puberty the brain protein deficit disappeared in rats whose mother received prednisone treatment, indicating that recovery, although slow, occurs in this parameter.
The decreased dry brain weight observed in this work may reflect the decreased content of proteins and lipids (Tables 1 and  2 ). In agreement with the results of Vernadakis and Woodbury (18), we found that brain water, expressed as milligrams per mg dry weight, decreased in newborn and 17-day-old rats from the control as well as from the relative treated sample groups in the course of development ( Table 1 ). The increment observed in 45-day-old treated rats is probably related to the deficient lipid deposition process. In the present study brain total lipids, cholesterol, and phospholipid concentration are decreased at 45 days in the treated rats. It is known that brain lipids, mainly cholesterol and phospholipids, are components of the myelin sheath (4). Cholesterol may be considered a satisfactory index (or estimation) of lipid deposition; it is involved in myelination because of its accumulation in the free form in the myelin sheath and because of its possible role on fatty acid transport (8) . Phospholipids, and most important among them, sphingomyelin, are also a component of myelin sheath in various mammalian s p e~i e s ; phospholipid concentration increases with cerebral development (13) . According to the present results it may be suggested that prenatal administration of 16-P-metilprednisone decreased postnatal deposit rate of lipids and hence, delayed myelination of the brain.
In previous works (5) it has been reported that the protein matrix seems to be a limiting factor in the myelination process. Antibodies to brain proteins can inhibit myelination in vitro, and probably proteins may serve to cement together the membranes at the myelin sheath.
The decreased brain lipid deposition observed in the animals whose mothers received prednisone may be caused by a deficient protein matrix at the beginning of the myelination process.
